Solid Biosciences Inc. (SLDB) Balance Sheet Quarterly - Discounting Cash Flows
SLDB
Solid Biosciences Inc.
SLDB (NASDAQ)
Period Ending: 2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q1)
03-31
2016 (Q4)
12-31
Report Filing: 2025-11-03 2025-08-12 2025-05-15 2025-03-06 2024-11-06 2024-08-13
1234
Total Current Assets 244.9 278.6 313.4 157.3 179.5 197.6
1234
Cash and Short Term Investments 236.1 268.1 306.9 148.9 171.1 190.3
1234
Cash & Equivalents 61.36 138.9 210.6 80.23 64.39 95.85
1234
Short Term Investments 174.8 129.2 96.29 68.69 106.7 94.41
1234
Receivables 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0
1234
Other Current Assets 8.71 10.53 6.49 8.38 8.38 7.34
1234
Total Assets 273.9 308.3 343.9 188.7 211.8 231
1234
Total Non-Current Assets 29.06 29.65 30.5 31.36 32.33 33.37
1234
Property, Plant and Equipment 26.89 27.45 28.2 29.04 29.93 30.95
1234
Goodwill and Intangible Assets 0 0 0 0 0 0
1234
Goodwill 0 0 0 0 0 0
1234
Intangible Assets 0 0 0 0 0 0
1234
Long Term Investments 0 0 0 0 0 1.91
1234
Deferred Tax Assets 0 0 0 0 0 0
1234
Other Long Term Assets 2.17 2.2 2.29 2.32 2.41 0.515
1234
Total Current Liabilities 36.34 29.85 28.78 30.26 22.85 14.69
1234
Accounts Payable 8.43 4.7 6.44 4.24 3.46 2.52
1234
Notes Payable/Short Term Debt 2.31 2.9 2.96 3.02 2.77 2.25
1234
Tax Payables 0 0 0 0 0 0
1234
Deferred Revenue 0 0 0 0 0 0
1234
Other Current Liabilities 25.6 22.25 19.38 23 16.63 9.92
1234
Total Liabilities 55.97 50 49.44 51.42 44.8 37.74
1234
Total Non-Current Liabilities 19.62 20.16 20.66 21.16 21.95 23.05
1234
Total Long Term Debt 19.62 20.16 20.66 21.16 21.95 23.05
1234
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0
1234
Deferred Revenue Non-Current 0 0 0 0 0 0
1234
Capital Lease Obligations 21.94 23.05 23.63 24.18 24.72 25.3
1234
Other Long Term Liabilities -21.94 -23.05 -23.63 -24.18 -24.72 -25.3
1234
Total Equity 217.9 258.3 294.5 137.2 167 193.2
1234
Non-Controlling Interest 0 0 0 0 0 0
1234
Total Stockholders' Equity 217.9 258.3 294.5 137.2 167 193.2
1234
Retained Earnings -908 -862.2 -822.7 -783.5 -740.9 -708.1
1234
Accumulated Other Earnings 0.048 -0.038 0.002 0.047 0.116 -0.015
1234
Common Stock 0.078 0.078 0.077 0.04 0.039 0.039
1234
Preferred Stock 0 0 0 0 0 0
1234
Additional Paid in Capital 1,126 1,120 1,117 920.6 907.7 901.3
1234
Total Liabilities & Total Equity 273.9 308.3 343.9 188.7 211.8 231
1234
Total Liabilities & Shareholders' Equity 273.9 308.3 343.9 188.7 211.8 231
1234
Total Investments 174.8 129.2 96.29 68.69 106.7 96.32
1234
Total Debt 21.94 23.05 23.63 24.18 24.72 25.3
1234
Net Debt -39.43 -115.9 -187 -56.06 -39.67 -70.56
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program